Combining oncolytic adenovirus with radiation – a paradigm for the future of radiosensitization

Combining oncolytic adenovirus with radiation – a paradigm for the future of radiosensitization

Oncolytic viruses and radiotherapy represent two diverse areas of cancer therapy, utilising quite different treatment modalities and with non-overlapping cytotoxicity profile. It is therefore an intriguing possibiltiy to consider that oncolytic ('cancer-killing') viruses may act as cancer-...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	O'Cathail, S, Pokrovska, TD, Maughan, TS, Fisher, KD, Seymour, LW, Hawkins, MA
Fformat:	Journal article
Cyhoeddwyd:	Frontiers Media 2017

Eitemau Tebyg

KEAP1-NRF2 pathway as a modulator of response to radiation in rectal cancer
gan: O'Cathail, S, et al.
Cyhoeddwyd: (2018)

Are all colorectal oligometastases equal?
gan: O'Cathail, S, et al.
Cyhoeddwyd: (2018)

A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)
gan: Séan M. O’Cathail, et al.
Cyhoeddwyd: (2020-06-01)

Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference
gan: Dyer, A, et al.
Cyhoeddwyd: (2018)

Attenuation of the hypoxia inducible factor pathway after oncolytic adenovirus infection coincides with decreased vessel perfusion
gan: Yousaf, I, et al.
Cyhoeddwyd: (2020)

Characterisation of a novel group B oncolytic adenovirus, ColoAd1
gan: Di, Y, et al.
Cyhoeddwyd: (2011)

Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells
gan: Dyer, A, et al.
Cyhoeddwyd: (2018)

Improving outcomes for resistant rectal cancer
gan: O'Cathail, S
Cyhoeddwyd: (2019)

A Renaissance for Oncolytic Adenoviruses?
gan: Paola Blanchette, et al.
Cyhoeddwyd: (2023-01-01)

Oncolytic Adenoviruses in Cancer Treatment
gan: Ramon Alemany
Cyhoeddwyd: (2014-02-01)

Oncolytic Adenoviruses in Gastrointestinal Cancers
gan: Raquel T. Yokoda, et al.
Cyhoeddwyd: (2018-03-01)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
gan: Bazan-Peregrino, M, et al.
Cyhoeddwyd: (2008)

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
gan: Freedman, J, et al.
Cyhoeddwyd: (2017)

Adenovirus as a Vector and Oncolytic Virus
gan: Wataru Matsunaga, et al.
Cyhoeddwyd: (2023-06-01)

Oncolytic adenovirus for treatment of malignant ascites
gan: Akseli Hemminki, et al.
Cyhoeddwyd: (2022-09-01)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
gan: William S. M. Wold, et al.
Cyhoeddwyd: (2010-08-01)

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
gan: Hanni Uusi-Kerttula, et al.
Cyhoeddwyd: (2015-11-01)

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
gan: Joshua D Freedman, et al.
Cyhoeddwyd: (2017-06-01)

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth
gan: Tedcastle, A, et al.
Cyhoeddwyd: (2016)

Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus
gan: Illingworth, S, et al.
Cyhoeddwyd: (2017)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
gan: Green, N, et al.
Cyhoeddwyd: (2012)

Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition
gan: Carlisle, R, et al.
Cyhoeddwyd: (2011)

Oncolytic adenoviruses and immunopeptidomics: a convenient marriage
gan: Marc Garcia‐Moure, et al.
Cyhoeddwyd: (2024-04-01)

Species D Adenoviruses as Oncolytic Viral Vectors
gan: Brianna L. Bullard, et al.
Cyhoeddwyd: (2020-12-01)

Cavitation-enhanced delivery of a self-amplifying oncolytic adenovirus for tumour-selective cancer therapy.
gan: Carlisle, R, et al.
Cyhoeddwyd: (2012)

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
gan: Sam Illingworth, et al.
Cyhoeddwyd: (2017-06-01)

NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
gan: Elaine Y.L. Leung, et al.
Cyhoeddwyd: (2020-03-01)

SBRT Pelvic re-irradiation: 2cm "rind" around PTV and small bowel dosimetry of rectal recurrences
gan: O'Cathail, S, et al.
Cyhoeddwyd: (2019)

Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.
gan: Bazan-Peregrino, M, et al.
Cyhoeddwyd: (2013)

Exploring the relationship between cancer metabolism and oncolytic adenoviruses
gan: Dyer, A
Cyhoeddwyd: (2021)

Bioprocessing of oncolytic group B adenovirus for scalable production
gan: Cooper, L
Cyhoeddwyd: (2014)

In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
gan: Victor A. Naumenko, et al.
Cyhoeddwyd: (2022-07-01)

Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
gan: Daoyuan Xie, et al.
Cyhoeddwyd: (2023-11-01)

Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy
gan: Ee Wern Tan, et al.
Cyhoeddwyd: (2022-10-01)

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
gan: Gabriela Green-Tripp, et al.
Cyhoeddwyd: (2022-06-01)

Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts
gan: Jing Li Huang, et al.
Cyhoeddwyd: (2016-09-01)

Oncolytic Replication of E1b-Deleted Adenoviruses
gan: Pei-Hsin Cheng, et al.
Cyhoeddwyd: (2015-11-01)

Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.
gan: Beatriz Vera, et al.
Cyhoeddwyd: (2016-01-01)

NRF2 Mediates Therapeutic Resistance to Chemoradiation in Colorectal Cancer through a Metabolic Switch
gan: Séan M. O’Cathail, et al.
Cyhoeddwyd: (2021-08-01)

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
gan: Mahasa, K, et al.
Cyhoeddwyd: (2020)